TITLE

Preliminary Evidence of a High Risk of Bleeding on Aspirin plus Clopidogrel in Aspirin-Na�ve Patients in the Acute Phase after TIA or Minor Ischaemic Stroke

AUTHOR(S)
herman, herman
PUB. DATE
August 2010
SOURCE
TEST DATA_New England Patriots EDSYS;test 1, p50
SOURCE TYPE
Book
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
52583443

 

Related Articles

  • COMMENTARY: Adding aspirin to clopidogrel increased bleeding without reducing recurrent ischemic vascular events in high-risk patients. Hankey, Graeme J. // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p68 

    The article presents a commentary on the study, which concluded that adding aspirin to clopidogrel increased bleeding without reducing recurrent ischemic vascular events in high-risk patients. The results of the MATCH trial are consistent with the known effects of aspirin in patients with TIA or...

  • Combination 'increases major bleeding risk'. Tanday, Sanjay // GP: General Practitioner;6/5/2009, p19 

    The article discusses a study which compares the risk of bleeding among 827 patients treated with either aspirin and clopidogrel in Great Britain. The study found that patients who took aspirin in combination with clopidogrel following a transient ischemic attack (TIA) may be at risk of...

  • Quantitative evaluation of wheat against volunteer rye in Iran.  // TEST DATA_New England Patriots EDSYS;7/6/2010 test, p2 

    Background: Aspirin plus clopidogrel (A+C) may be more effective than aspirin only (AO) acutely after TIA and minor stroke, but the risk of bleeding in the acute phase is uncertain. We determined this risk, focusing particularly on aspirin-na�ve patients. Methods: We studied consecutive...

  • Adding clopidogrel to aspirin after TIA or minor ischemic stroke reduced stroke without increasing bleeding. Y. Wang; Johnston, S. C.; Hill, Michael D. // Annals of Internal Medicine;10/15/2013, Vol. 159 Issue 8, pJC5 

    The article presents a study that explored whether adding clopidogrel to aspirin reduce recurrent stroke in patients with acute high-risk transient ischemic attack (TIA) or minor ischemic stroke, and states that the results of the study suggested that addition of clopidogrel to aspirin reduced...

  • Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease. Aronow, W.S. // Drugs & Aging;1999, Vol. 15 Issue 2, p91 

    Antiplatelet drugs have been demonstrated to reduce the incidence of myocardial infarction (MI), stroke or vascular death in patients with vascular disease. There are no data suggesting that antiplatelet therapy acts differently in older people than in younger people and recommendations based on...

  • 2013 - Adding clopidogrel to aspirin after TIA or minor ischemic stroke reduced stroke without increasing bleeding. Hill, Michael D. // ACP Journal Club;10/15/2013, Vol. 159 Issue 8, p1 

    The article presents a study related to the effect of the addition of clopidogrel to aspirin reduce recurrent stroke patients with acute high-risk transient ischemic attack (TIA) or minor ischemic stroke. The method includes a randomized controlled trial performed on 5170 adults of 40 years of...

  • Adding aspirin to clopidogrel increased bleeding without reducing recurrent ischemic vascular events in high-risk patients.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p68 

    The article addresses the question whether in high-risk patients who have had a transient ischemic attack (TIA) or recent ischemic stroke, aspirin plus clopidogrel is more effective than clopidogrel alone for reducing recurrent ischemic. vascular events. The article concludes that In high-risk...

  • Adverse Effects and Drug Interactions of Antithrombotic Agents Used in Prevention of Ischaemic Stroke. Weinberger, Jesse // Drugs;2005, Vol. 65 Issue 4, p461 

    Stroke is the third most common cause of death in the US. Primary prevention of stroke can be achieved by control of risk factors including hypertension, diabetes mellitus, elevated cholesterol levels and smoking. Approximately one-third of all ischaemic strokes occur in patients with a history...

  • Pharmacotherapy for the Secondary Prevention of Stroke. Toyoda, Kazunori // Drugs;2009, Vol. 69 Issue 6, p633 

    Stroke recurrence continues to be the major risk for stroke survivors. Risk factor control and antithrombotic medication are two major strategies for patients with a prior stroke or transient ischaemic attack (TIA) to prevent stroke recurrence. Hypertension, dyslipidaemia and diabetes mellitus...

  • Clopidogrel could reduce stroke risk.  // Infectious Disease Alert;Aug2013 Pharmacology Watch, p1 

    The article discusses research on the impact of clopidogrel in reducing stroke risk, published online in "New England Journal of Medicine" on June 26, 2013. About 5200 patients were seen within 24 hours after onset of minor ischemic stroke or high-risk transient ischemic attack (TIA) and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics